Molecular Oncology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish contributions novel findings in research to molecular aspects of all types of human cancers. This section ranges from basic sciences to preclinical research. We encourage submission of high-quality manuscripts that provide novel mechanistic insights and details of the molecular signatures of oncogenic transformation. We also encourage submission of high-quality manuscripts that focus on translating basic molecular knowledge to new clinical applications in oncology. The scope of this section includes, but is not limited to, the following:
- Biological processes, like gene activity in relation with specific molecular pathways, in the development and progression of cancers
- Mechanisms of metastasis (vascular and lymphatic dissemination and seeding)
- Molecular interactions in the tumor microenvironment, including tumor-immune interactions
- Genomic profiling of human cancers and any other ‘systems biology’ approaches in understanding development of human cancers
- Preclinical research that leads to novel therapies derived from molecular processes and cellular interactions, including gene therapy, therapy based on biologicals, hormonal therapy, and cancer vaccines and other types of immunotherapies
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Immunotherapy in Tumors: Treatments, Complications and Diagnostic Evaluation of Response (Deadline: 20 May 2024)
- Cancer: Molecular Research and Novel Inflammatory Targets (Deadline: 20 May 2024)
- Aldehyde Dehydrogenase in Cancer (Deadline: 20 May 2024)
- Cancer Suicide Gene Therapy (Deadline: 20 May 2024)
- Molecular Research Progress on Glioblastoma (Deadline: 20 May 2024)
- Role of MicroRNAs in Cancer Development and Treatment 2.0 (Deadline: 20 May 2024)
- Molecular Mechanisms and Immunotherapy of Soft Tissue and Bone Sarcomas (Deadline: 20 May 2024)
- Molecular Mechanisms and Therapies of Glioblastoma (Deadline: 20 May 2024)
- Circulating Cell-Free Nucleic Acids and Cancers 2.0 (Deadline: 25 May 2024)
- Advances in Pathogenesis and Treatment of Skin Cancer (Deadline: 25 May 2024)
- Latest Progress in Cancer Cell Communications (Deadline: 29 May 2024)
- Molecular Basis and Advances of Targeted Therapy for Breast Cancer (Deadline: 30 May 2024)
- Reprogramming the Tumor Microenvironment in Pancreatic Cancer (Deadline: 30 May 2024)
- Molecular Mechanisms of Angiogenesis and Cancer (Deadline: 30 May 2024)
- Pathophysiology to Novel Therapeutic Approaches for Leukemia (Deadline: 30 May 2024)
- Current Research on Cancer Biology and Therapeutics 2.0 (Deadline: 30 May 2024)
- Advanced Research on Obesity and Cancer (Deadline: 30 May 2024)
- Molecular Mechanisms and Therapies of Colorectal Cancer 3.0 (Deadline: 30 May 2024)
- Viral Infections and Cancer: Recent Advances and Future Perspectives (Deadline: 30 May 2024)
- Bladder Cancer: Molecular Advances in Pathology, Diagnostics and Therapeutics 2.0 (Deadline: 31 May 2024)
- Fifty Years of Targeted Therapy in Cancer: Past, Present and Future (Deadline: 31 May 2024)
- Editorial Board Members’ Collection Series: Cancer Metabolism (Deadline: 31 May 2024)
- Molecular Research on Genitourinary Cancers (Deadline: 31 May 2024)
- Emerging Therapeutic Targets for Solid Tumors (Deadline: 31 May 2024)
- Hormone Signaling in Cancers and Cancer-Promoting Pathologies (Deadline: 31 May 2024)
- Molecular Biology of Tumor Cells: Present and Future (Deadline: 31 May 2024)
- Regulation and Targeting of Ferroptosis in Tumor and Beyond (Deadline: 31 May 2024)
- Recent Insights into Colorectal Cancer Treatment (Deadline: 31 May 2024)
- Editorial Board Members’ Collection Series: Nanomedicine in Cancer (Deadline: 31 May 2024)
- Editorial Board Members’ Collection Series: Cancer Metastasis (Deadline: 31 May 2024)
- Mesenchymal Stem Cells and Cancer (Deadline: 31 May 2024)
- Immunotherapy versus Immune Modulation of Leukemia (Deadline: 31 May 2024)
- Molecular Mechanisms of Inhibition of Colorectal Cancer (Deadline: 31 May 2024)
- New Molecular Mechanisms and Advanced Therapies for Solid Tumors (Deadline: 31 May 2024)
- Molecular Insights into Epigenetics in Cancer (Deadline: 31 May 2024)
- Molecular Mechanisms and Therapies of Hematological Tumors (Deadline: 31 May 2024)
- Endometrial Cancer: From Molecular Pathology to Novel Therapeutic Approaches (Deadline: 31 May 2024)
- Molecular Mechanisms in Tumorigenesis of NMSC (Deadline: 31 May 2024)
- Molecular Mechanism of Cancer Research and Therapies (Deadline: 31 May 2024)
- Growth Hormone Tumor: Molecular Pathologies, Diagnosis, and Therapeutic Strategies (Deadline: 31 May 2024)
- Tumor-Immune Interactions (Deadline: 31 May 2024)
- Recent Molecular Trends and Prospects in Pancreatic Cancer (Deadline: 31 May 2024)
- Colorectal Cancer: A Molecular Genetics Perspective (Deadline: 10 June 2024)
- Recent Molecular Research for Glioblastoma (Deadline: 10 June 2024)
- Current Research on Cancer Drug Resistance (Deadline: 10 June 2024)
- Radiobiology and Radiotherapy in Tumour (Deadline: 10 June 2024)
- Emerging Therapies for Glioblastoma (Deadline: 15 June 2024)
- Molecular Mechanisms and Therapies of Lung Cancer (Deadline: 15 June 2024)
- The Transcriptome Complexity in Cancer and Leukemia: Alternative Splicing and Beyond (Deadline: 15 June 2024)
- Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment (Deadline: 15 June 2024)
- From Basic Science to Treatment Strategies: Personalized Cancer Therapy (Deadline: 15 June 2024)
- Tumor Microenvironment in Cancer Cell Metastasis (Deadline: 15 June 2024)
- Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment 2.0 (Deadline: 16 June 2024)
- The Mast Cell in Breast Cancer: Friend or Foe (Deadline: 16 June 2024)
- Innovative Approaches for Targeted Cancer Therapies (Deadline: 16 June 2024)
- Molecular Biology of the Thyroid Cancer and Thyroid Dysfunctions (Deadline: 20 June 2024)
- Trends and Prospects in Electroporation-Based Treatment for Tumors (Deadline: 20 June 2024)
- Cancer-Related Biochemical Pathways: From Tumor Outgrowth, Metastasis to Novel Targeted Therapy (Deadline: 20 June 2024)
- Advances in Proteomics in Cancer (Deadline: 20 June 2024)
- Lung Cancer: From Molecular Mechanisms to Novel Therapeutics (Deadline: 20 June 2024)
- Molecular Research on Breast Cancer Diagnosis and Treatment (Deadline: 20 June 2024)
- Breast Cancer, Metastatic Breast Cancer, Therapeutic Approaches 2.0 (Deadline: 21 June 2024)
- MicroRNAs in Cancer Therapy 2.0 (Deadline: 25 June 2024)
- The Roles of Photodynamic Therapy in Tumors and Cancers (Deadline: 28 June 2024)
- New Anti-cancer Drugs: The Past, Present and Future (Deadline: 28 June 2024)
- Current Research for Castration Resistance Prostate Cancer (Deadline: 28 June 2024)
- Advances in Tumor Necrosis Factor and Inflammatory Diseases (Deadline: 29 June 2024)
- State-of-the-Art Molecular Oncology in Brazil 3.0 (Deadline: 29 June 2024)
- Paracrine and Metabolic Adaptation in Cancer Progression (Deadline: 30 June 2024)
- Advance in Targeted Cancer Therapy and Mechanisms of Resistance—2nd Edition (Deadline: 30 June 2024)
- Gastrointestinal Cancer: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 June 2024)
- The Occurrence, Evolution and Treatment of Glioblastoma 2.0 (Deadline: 30 June 2024)
- The Emerging Role of Neutrophils in Cancer: Molecular Aspects of Plasticity and Potential Therapeutic Targets (Deadline: 30 June 2024)
- miRNAs in Carcinogenesis of Solid and Hematological Malignancies (Deadline: 30 June 2024)
- Optical Molecular Imaging in Cancer Research and Diagnosis (Deadline: 30 June 2024)
- Cancer Genomics and Precision Oncology (Deadline: 30 June 2024)
- Gynecological Cancer 2024 (Deadline: 30 June 2024)
- Molecular Research Targeting Plasma-Cell Myeloma (Deadline: 30 June 2024)
- Molecular Biomarkers in Cancers: Advances and Challenges (Deadline: 30 June 2024)
- Chronic Liver Disease and Hepatocellular Carcinoma (Deadline: 30 June 2024)
- Editorial Board Members’ Collection Series: Genetic and Molecular Intricacies Underlying Brain Tumors (Deadline: 30 June 2024)
- NK Cells, Immune Response in Pathology and Cancer 2.0 (Deadline: 30 June 2024)
- Fibrosis in Inflammation and Cancer (Deadline: 30 June 2024)
- Epigenetics and Immunotherapy in Cancer (Deadline: 30 June 2024)
- Insights in Molecular Therapies for Hepatocellular Carcinoma (Deadline: 30 June 2024)
- Precision Cancer Medicine: Molecular Biological Insights, Biological Events and Clinical Perspective (Deadline: 30 June 2024)
- Targeted Therapies and Molecular Methods in Cancer 2.0 (Deadline: 30 June 2024)
- New Research on Oral Fibrosis and Oral Cancer (Deadline: 30 June 2024)
- Therapeutic Strategies to Target Cancer Neoantigens (Deadline: 30 June 2024)
- Molecular Biological Insights and Targeted Therapies for Sarcomas (Deadline: 30 June 2024)
- Current and Future Roles of Tumor Markers in Prostate Adenocarcinoma (Deadline: 30 June 2024)
- Molecular Research and Treatment of Prostate Cancer (Deadline: 30 June 2024)
- Oncoprotein Mechanisms: Prospects in Treatment (Deadline: 30 June 2024)
- Molecular Advances in Gynecologic Cancer (Deadline: 30 June 2024)
- Molecular Research on Gynecological Cancers: Ovarian Cancer, Endometrial Cancer, and Gestational Trophoblastic Disease (Deadline: 30 June 2024)
- Recent Advances in Cancer Chemoprevention: Focus on Natural Product (Deadline: 30 June 2024)
- Prostate Cancer: From Molecular Diagnosis to Treatment (Deadline: 30 June 2024)
- The Carcinogenetic Potential of Human Papilloma Virus: From Experimental Studies to Targeted Therapy (Deadline: 30 June 2024)
- Functional Role of Non-coding RNAs in Cancer: Inside and outside Cells (Deadline: 30 June 2024)
- New Biomarkers and Therapeutics in Hematological Neoplasias (Deadline: 10 July 2024)
- Cellular Intrinsic Modulators in the Pathogenesis of Cancer and Inflammatory Diseases (Deadline: 15 July 2024)
- Role of p53 Family in Targeted Therapy of Cancers (Deadline: 20 July 2024)
- Advances in Lung Cancer: From Genetic Landscape to Treatment (Deadline: 20 July 2024)
- Gastrointestinal Disorder and Cancer: Biochemical and Molecular Insight (Deadline: 25 July 2024)
- Integrative Multi-Omics Analysis for Cancer Biomarkers (Deadline: 25 July 2024)
- Targeting Epigenetics in Cancer Therapy (Deadline: 25 July 2024)
- Molecular Biology on Cancer Genomics, Precision Medicine and Public Health (Deadline: 25 July 2024)
- Molecular Mechanism and Treatment of Hemangioma (Deadline: 25 July 2024)
- Targeted Therapy and Molecular Strategies for Gynecological Cancer (Deadline: 25 July 2024)
- Insights into Chronic Liver Disease and Hepatocellular Carcinoma (Deadline: 30 July 2024)
- Recent Advances in Gastrointestinal Cancer 2.0 (Deadline: 30 July 2024)
- Molecular Research of Chronic Lymphocytic Leukemia (CLL) (Deadline: 30 July 2024)
- Molecular Biology and Targeted Therapies in Leukemias (Deadline: 30 July 2024)
- Novel Therapeutic Targets in Cancers 3.0 (Deadline: 30 July 2024)
- Molecular Regulation Mechanisms of Tumor Progression: State-of-the-Art and Future Perspectives (Deadline: 30 July 2024)
- Acute Leukemia: From Basic Research to Clinical Application (Deadline: 30 July 2024)
- Advances and Mechanisms in Breast Cancer (Deadline: 30 July 2024)
- Molecular Genetics of Breast Cancer—Recent Progress (Deadline: 30 July 2024)
- Pathogenesis and Therapy of Oral Carcinogenesis 2.0 (Deadline: 30 July 2024)
- Genomic Oncology and Medicine in Leukemia: From Molecular Pathogenesis to Novel Therapeutic Approaches (Deadline: 30 July 2024)
- Novel Biomarkers and Molecular Targets in Gliomas (Deadline: 30 July 2024)
- Advances in Cancer Chemoprevention and Therapeutics (Deadline: 31 July 2024)
- Gynecologic Cancer: From Molecular, Cellular Mechanisms to Novel Therapies (Deadline: 31 July 2024)
- Advanced Research on Biomarkers in Gastrointestinal Cancer 2.0 (Deadline: 31 July 2024)
- Epigenetic Genes, Biomarkers and Immunotherapy in Cancers (Deadline: 31 July 2024)
- Biomarkers of Tumor Progression, Prognosis and Therapy 2.0 (Deadline: 31 July 2024)
- Recent Advances in Anti-Cancer Drugs (Deadline: 31 July 2024)
- Recent Advances in Cancer Biomarkers, Artificial Intelligence and Emerging Technologies (Deadline: 31 July 2024)
- Molecular Research of Multi-omics in Cancer (Deadline: 31 July 2024)
- Molecular Targeted Therapy for Gliomas (Deadline: 31 July 2024)
- Proteomics of Human Peripheral Blood Mononuclear Cells in Cancer (Deadline: 31 July 2024)
- New Insights into Radiation Oncology (Deadline: 31 July 2024)
- The Role of Macrophages in Cancers (Deadline: 31 July 2024)
- Roles of Migration and Invasion in Cancer Metastasis (Deadline: 31 July 2024)
- Molecular Mechanism of Gastric Cancer (Deadline: 31 July 2024)
- Integrative Oncology: From the Lab to New Therapeutic Possibilities—2nd Edition (Deadline: 31 July 2024)
- Molecular Mechanisms and Therapies of Malignant Mesothelioma 2.0 (Deadline: 31 July 2024)
- New Insights into Cancer Metabolism: Signaling Pathways and Therapeutic Targets (Deadline: 31 July 2024)
- Latest Review Papers in Molecular Oncology 2024 (Deadline: 31 July 2024)
- Renal Cell Carcinoma: Novel Insights into Pathophysiology, Diagnosis and Therapy (Deadline: 31 July 2024)
- Advances in Head and Neck and Skin Cancer (Deadline: 31 July 2024)
- Molecular Basis of Odontogenic Tumors and Odontogenic Cysts (Deadline: 15 August 2024)
- New Perspectives in Prostate Cancer: From Pathophysiology to Novel Therapies (Deadline: 15 August 2024)
- Molecular Diagnostics and Genomics of Tumors (Deadline: 15 August 2024)
- Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers 2.0 (Deadline: 15 August 2024)
- Metals and Cancer (Deadline: 20 August 2024)
- Melatonin and Vitamins: New Insights into Cancer Therapies (Deadline: 29 August 2024)
- The Role of Extracellular Vesicles in Cancer Diagnosis and Therapy 2.0 (Deadline: 29 August 2024)
- Molecular Therapies and Mechanisms of Gynecological Cancers (Deadline: 30 August 2024)
- Non-small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 30 August 2024)
- Small Cell Lung Cancer Entering the Sphere of Personalized Treatment (Deadline: 30 August 2024)
- Molecular Mechanisms of HPV-Induced Carcinogenesis (Deadline: 31 August 2024)
- Navigating Precision Oncology: Integrating Biomarkers into Clinical Practice (Deadline: 31 August 2024)
- Signaling Pathways Dysregulation in Cancer: Advances and New Therapeutics Hopes (Deadline: 31 August 2024)
- Molecular Research of DNA Methylation in Cancer Therapy (Deadline: 31 August 2024)
- Pituitary Tumors: An Update in the Pathogenetic Mechanisms, the Diagnostic Methods and the Therapeutic Approaches (Deadline: 31 August 2024)
- Advances and Insights in Tumorogenesis and Tumor Metastasis (Deadline: 31 August 2024)
- New Insights into Colorectal Cancer (Deadline: 31 August 2024)
- Biomarkers, Treatments, and Clinical Outcomes for Meningiomas and Other Skull Base Tumors (Deadline: 31 August 2024)
- Human Papillomavirus and Cancers: Advances and Future Prospects (Deadline: 31 August 2024)
- Intercellular Communication in the Tumor Microenvironment (Deadline: 31 August 2024)
- Antitumor and Anti-infective Agents from Marine Organisms (Deadline: 31 August 2024)
- Targeted Radioligand Therapy and Immunotherapy for Cancer Treatment (Deadline: 31 August 2024)
- Colorectal Cancer: Molecular Mechanism and Treatment Strategies (Deadline: 31 August 2024)
- Brain Tumors: From Biomarkers to Novel Therapies (Deadline: 31 August 2024)
- Unveiling the Molecular Landscape through Next-Generation Liquid Biopsy (Deadline: 31 August 2024)
- Leukemia and Lymphoma: A Focus on Molecular Genetics Research (Deadline: 31 August 2024)
- Cell Apoptosis in Cancers: Regulation Factors (Deadline: 31 August 2024)
- Cancer Biomarker: Current Status and Future Perspectives (Deadline: 15 September 2024)
- Liver Cancer 3.0 (Deadline: 20 September 2024)
- Advances and Perspectives in Molecular Tumor Therapy (Deadline: 20 September 2024)
- Genomics and Proteomics of Cancer Cell Survival and Development (Deadline: 20 September 2024)
- Advances in Glioblastoma: Bridging Genetics, Epigenetics, Immunology and Pathophysiology to Advanced Therapies (Deadline: 20 September 2024)
- Molecular Research and Treatment of Breast Cancer 3.0 (Deadline: 20 September 2024)
- New Diagnostic Tools and Biomarkers in Oncological Diseases 2.0 (Deadline: 20 September 2024)
- Molecular Advances in Gastric Cancer (Deadline: 20 September 2024)
- Update on Immunotherapies for Cancer (Deadline: 20 September 2024)
- Cutting Edge Advances in Prostate Cancer (Deadline: 20 September 2024)
- Molecular Aspects of Adrenal Diseases and Carcinoma (Deadline: 20 September 2024)
- Antibody Therapy for Hematologic Malignancies (Deadline: 20 September 2024)
- Lung Cancer: From Molecular Basis to Genome-Guided Therapy and Immunotherapy 2.0 (Deadline: 20 September 2024)
- The Multiple Faces of Non-small Cell Lung Cancer: Targeted Therapies and Recent Developments (Deadline: 20 September 2024)
- Advances in the Diagnosis and Treatment of Non-small Cell Lung Cancer (Deadline: 20 September 2024)
- Predictive, Prognostic Biomarkers and Therapeutic Targets of Breast Cancer (Deadline: 20 September 2024)
- Cancer Genomics (Deadline: 20 September 2024)
- Natural Products in Cancer Treatments (Deadline: 20 September 2024)
- Advances in Molecular Biology and Treatment of Thymic Epithelial Tumors (Deadline: 20 September 2024)
- Molecular Developments and Prospects in Thyroid Cancer (Deadline: 25 September 2024)
- Molecular Mechanisms and Therapies of Brain Tumors (Deadline: 25 September 2024)
- Emerging Treatment of Glioblastoma Multiforme (Deadline: 29 September 2024)
- Advances in the Molecular Diagnosis and Treatment of Pancreatic Cancer (Deadline: 30 September 2024)
- Molecular Aspects of Cancer Radiotherapy (Deadline: 30 September 2024)
- Therapeutic Targets in Pancreatic Cancer: 2nd Edition (Deadline: 30 September 2024)
- Molecular Mechanisms and Therapies of Myeloid Leukaemia 3.0 (Deadline: 30 September 2024)
- Deciphering the Dynamics: Exploring Tumor Evolution in Cancer (Deadline: 30 September 2024)
- Melanoma: Molecular Mechanisms and Therapy (Deadline: 30 September 2024)
- Molecular and Therapeutic Advanced Research in Prostate Cancer (Deadline: 30 September 2024)
- The Role of Hormonal Receptors in Cancer: Molecular Mechanisms and Targeted Therapies (Deadline: 30 September 2024)
- Cancer Cell Metabolism: New Advances and Potential Therapies (Deadline: 30 September 2024)
- Novel Therapeutic Strategies for Gynecological Cancer: Molecular Biological Insights (Deadline: 30 September 2024)
- Metabolomics in Oncology (Deadline: 30 September 2024)
- Recent Advances in Gastrointestinal Tract Oncology: Pathology, Diagnostics and Therapy (Deadline: 30 September 2024)
- Pathogenesis and Molecular Treatment of Primary Liver Cancer (Deadline: 30 September 2024)
- Reproduction and Cancer: Cell-Cell Interaction and Signal Transduction (Deadline: 30 September 2024)
- The Hallmarks of Cancer Stem Cells (Deadline: 30 September 2024)
- Recent Developments in Omics Technologies Applied to Oncology Research (Deadline: 30 September 2024)
- Challenges and Future Perspectives in Treatment for Lung Cancer (Deadline: 30 September 2024)
- Precision Medicine in Oncology 2.0 (Deadline: 30 September 2024)
- The Role of MicroRNA in Tumor Development and Treatment (Deadline: 30 September 2024)
- Exploring Molecular Mechanisms of Biomarkers in Cancer Treatment (Deadline: 30 September 2024)
- Molecular Mechanisms Underlying Pancreatic Cancer Progression and Drug Resistance (Deadline: 30 September 2024)
- Cancer Immunotherapy: Tumor Microenvironment, Biomarker Discovery and Immune Resistance 2.0 (Deadline: 30 September 2024)
- Targeted Treatments in Cancer 2.0 (Deadline: 30 September 2024)
- Microbiota and Cancer 4.0 (Deadline: 30 September 2024)
- Glioblastoma: From Molecular Mechanisms to Therapies (Deadline: 30 September 2024)
- The Discovery and Characterization of New Oncological Molecules (Deadline: 15 October 2024)
- Biomarkers and Early Detection Strategies of Ovarian Tumors (Deadline: 15 October 2024)
- Pathogenesis and Treatments of Head and Neck Cancer (Deadline: 20 October 2024)
- Molecular Research on the Pancreatic Cancer (Deadline: 20 October 2024)
- Molecular Pathology and Novel Therapies for Head and Neck Cancer (Deadline: 20 October 2024)
- RNA-Based Diagnostics and Therapeutics for Colorectal Cancer (Deadline: 20 October 2024)
- Invasion and Metastasis in Brain Cancer (Deadline: 20 October 2024)
- New Advances in B-cell Lymphoma Biology (Deadline: 20 October 2024)
- Molecular Pathology, Signaling, and Drug Resistance in Hepatocellular Carcinoma (Deadline: 30 October 2024)
- Molecular Research and New Therapy in Melanoma and Other Skin Cancers 2.0 (Deadline: 30 October 2024)
- Translational Oncology: From Molecular Basis to Therapy (Deadline: 30 October 2024)
- Novel Insights into Myeloid Neoplasms: From Pathogenesis to Targeted Therapies (Deadline: 31 October 2024)
- Molecular, Translational and Clinical Research of Cancer Structural Biomarkers (Deadline: 31 October 2024)
- Oncolytic Viruses for Cancer Immunotherapy (Deadline: 31 October 2024)
- Non-coding RNA (ncRNA) in Cancer 2.0 (Deadline: 31 October 2024)
- New Molecular Advances in Lung Cancer (Deadline: 31 October 2024)
- Novel Therapeutic Interventions and Drug Targets for Treatment of Cancer (Deadline: 31 October 2024)
- Advanced Molecular Research in Tumors (Deadline: 31 October 2024)
- Mechanistic Insights into Cancer Immunotherapy and Immune-Related Adverse Events (Deadline: 31 October 2024)
- Molecular Research and Novel Therapy of Pancreatic Cancer (Deadline: 31 October 2024)
- Targeting Apoptotic Pathways in Cancer Therapy (Deadline: 31 October 2024)
- Cancer Biology: From Genetic Aspects to Treatment (Deadline: 31 October 2024)
- Molecular Insights into Glioblastoma Pathogenesis: Focus on Progenitor Cells, Microglia and Noncoding RNA (Deadline: 31 October 2024)
- Molecular Mechanisms and Therapies of Pancreatic Cancer 2.0 (Deadline: 15 November 2024)
- Molecular Research on Lung Cancer: Translational Perspectives (Deadline: 30 November 2024)
- The 50th Anniversary of the Discovery of Reciprocal Translocation between Chromosome 9 and 22: The Impact on Molecular and Genomic Knowledge on Cancer (Deadline: 30 November 2024)
- Estrogen Receptor α-Negative Breast Cancer: Pathology and Genetics for Novel Therapeutic Approaches (Deadline: 30 November 2024)
- Mutant p53 in Cancers (Deadline: 30 November 2024)
- Molecular Biology of Cancer—Implications for Diagnosis and Treatment 2.0 (Deadline: 5 December 2024)
- Tumor Microenvironments: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression (Deadline: 31 December 2024)
- Breast Cancers: From Molecular Basis to Therapy (Deadline: 31 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions: